{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:26:19Z","timestamp":1793366779813,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.clinre.2019.12.001","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T09:35:36Z","timestamp":1578389736000},"page":"543-550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Effect of mycophenolic acid on inosine monophosphate dehydrogenase (IMPDH) activity in liver transplant patients"],"prefix":"10.1016","volume":"44","author":[{"given":"M.","family":"Neuberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sommerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"B\u00f6hnisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Metzendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6163-1525","authenticated-orcid":false,"given":"A.","family":"Mehrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Stremmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Gotthardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Zeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.H.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2808-9230","authenticated-orcid":false,"given":"C.","family":"Rupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clinre.2019.12.001_bib0210","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bpg.2017.03.001","article-title":"Modification of immunosuppressive therapy as risk factor for complications after liver transplantation","volume":"31","author":"De Simone","year":"2017","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.clinre.2019.12.001_bib0215","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/lt.23566","article-title":"Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation","volume":"19","author":"Lucey","year":"2013","journal-title":"Liver Transplant"},{"issue":"10","key":"10.1016\/j.clinre.2019.12.001_bib0220","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1111\/j.1600-6143.2012.04157.x","article-title":"Calcineurin inhibitor sparing with mycophenolate mofetil in liver transplantion: a systematic review of randomized controlled trials","volume":"12","author":"Goralczyk","year":"2012","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.clinre.2019.12.001_bib0225","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1432-2277.2008.00796.x","article-title":"Calcineurin inhibitor minimization protocols in liver transplantation","volume":"22","author":"Farkas","year":"2009","journal-title":"Transplant Int"},{"issue":"Suppl. 1","key":"10.1016\/j.clinre.2019.12.001_bib0230","article-title":"Indications of mycophenolate mofetil in liver transplantation","volume":"80","author":"Klupp","year":"2005","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.clinre.2019.12.001_bib0235","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/lt.23658","article-title":"Calcineurin inhibitor-free mycophenolate mofetil\/sirolimus maintenance in liver transplantation: the randomized spare-the-nephron trial","volume":"19","author":"Teperman","year":"2013","journal-title":"Liver Transplant"},{"issue":"7","key":"10.1016\/j.clinre.2019.12.001_bib0240","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1016\/j.transproceed.2012.07.124","article-title":"Significance of mycophenolate monitoring in liver transplant recipients: toward the cut-off level","volume":"44","author":"Sarvary","year":"2012","journal-title":"Transplant Proc"},{"issue":"9256","key":"10.1016\/j.clinre.2019.12.001_bib0245","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(00)04055-1","article-title":"Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study","volume":"357","author":"Schlitt","year":"2001","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.clinre.2019.12.001_bib0250","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1600-6143.2008.02529.x","article-title":"Mycophenolate mofetil monotherapy for severe side effects of calcineurin inhibitors following liver transplantation","volume":"9","author":"Dharancy","year":"2009","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.clinre.2019.12.001_bib0255","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2125.2009.03612.x","article-title":"Pharmacokinetic and pharmacodynamic analysis of enteric-coated mycophenolate sodium: limited sampling strategies and clinical outcome in renal transplant patients","volume":"69","author":"Sommerer","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinre.2019.12.001_bib0260","first-page":"31","article-title":"Isolation of leucocytes from human blood. Further observations. Methylcellulose, dextran, and ficoll as erythrocyteaggregating agents","volume":"97","author":"Boyum","year":"1968","journal-title":"Scand J Clin Lab Invest Supplement"},{"issue":"7","key":"10.1016\/j.clinre.2019.12.001_bib0265","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0009-9120(01)00267-3","article-title":"Non-radioactive determination of inosine 5\u2019-monophosphate dehydro-genase (IMPDH) in peripheral mononuclear cells","volume":"34","author":"Glander","year":"2001","journal-title":"Clin Biochem"},{"issue":"3","key":"10.1016\/j.clinre.2019.12.001_bib0270","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/FTD.0b013e31819c3f3d","article-title":"Improved assay for the nonradioactive determination of inosine 5\u2019-monophosphate dehydrogenase activity in peripheral blood mononuclear cells","volume":"31","author":"Glander","year":"2009","journal-title":"Ther Drug Monitor"},{"issue":"78","key":"10.1016\/j.clinre.2019.12.001_bib0275","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1016\/S0041-1345(01)02407-1","article-title":"Pharmacodynamic monitoring of mycophenolate mofetil in renal allograft recipients","volume":"33","author":"Budde","year":"2001","journal-title":"Transplant Proc"},{"issue":"2","key":"10.1016\/j.clinre.2019.12.001_bib0280","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/FTD.0b013e31803d37b6","article-title":"Monitoring of inosine monophosphate dehydrogenase activity as a biomarker for mycophenolic acid effect: potential clinical implications","volume":"29","author":"Weimert","year":"2007","journal-title":"Therapeutic Drug Monitor"},{"issue":"Suppl 4","key":"10.1016\/j.clinre.2019.12.001_bib0285","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/ndt\/14.suppl_4.33","article-title":"Pharmacokinetics of mycophenolic acid (MPA) and free MPA in paediatric renal transplant recipients--a multicentre study. The German Study Group on Mycophenolate Mofetil (MMF) Therapy","volume":"14","author":"Weber","year":"1999","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.clinre.2019.12.001_bib0290","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2125.2004.02235.x","article-title":"Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant","volume":"59","author":"Atcheson","year":"2005","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.clinre.2019.12.001_bib0295","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/FTD.0b013e3182a13900","article-title":"Simultaneous quantification of IMPDH activity and purine bases in lymphocytes using LC-MS\/MS: assessment of biomarker responses to mycophenolic acid","volume":"36","author":"Vethe","year":"2014","journal-title":"Ther Drug Monitor"},{"issue":"1","key":"10.1016\/j.clinre.2019.12.001_bib0300","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/FTD.0b013e31829dcb66","article-title":"Tacrolimus exposure and mycophenolate pharmacokinetics and pharmacodynamics early after liver transplantation","volume":"36","author":"Saeves","year":"2014","journal-title":"Ther Drug Monitor"},{"issue":"2","key":"10.1016\/j.clinre.2019.12.001_bib0305","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/00365513.2012.745947","article-title":"Mycophenolate pharmacokinetics and inosine monophosphate dehydrogenase activity in liver transplant recipients with an emphasis on therapeutic drug monitoring","volume":"73","author":"Reine","year":"2013","journal-title":"Scand J Clin Lab Invest"},{"issue":"3","key":"10.1016\/j.clinre.2019.12.001_bib0310","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2215\/CJN.06050809","article-title":"Pharmacokinetics and pharmacodynamics of intensified versus standard dosing of mycophenolate sodium in renal transplant patients","volume":"5","author":"Glander","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.clinre.2019.12.001_bib0315","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/rheumatology\/keq238","article-title":"Proton pump inhibitors interfere with the immunosuppressive potency of mycophenolate mofetil","volume":"49","author":"Schaier","year":"2010","journal-title":"Rheumatology (Oxford, England)"},{"issue":"4","key":"10.1016\/j.clinre.2019.12.001_bib0320","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/bcp.13154","article-title":"The pharmacokinetics and pharmacodynamics of mycophenolate mofetil in younger and elderly renal transplant recipients","volume":"83","author":"Tang","year":"2017","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.clinre.2019.12.001_bib0325","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/FTD.0b013e3182852697","article-title":"Inosine monophosphate dehydrogenase expression and activity are significantly lower in kidney transplant recipients with diabetes mellitus","volume":"35","author":"Dostalek","year":"2013","journal-title":"Ther Drug Monitor"},{"issue":"2","key":"10.1016\/j.clinre.2019.12.001_bib0330","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/FTD.0b013e31819743d9","article-title":"Pharmacokinetics of mycophenolic acid and its glucuronide metabolites in stable adult liver transplant recipients with renal dysfunction on a low-dose calcineurin inhibitor regimen and mycophenolate mofetil","volume":"31","author":"Beckebaum","year":"2009","journal-title":"Ther Drug Monitor"},{"issue":"1","key":"10.1016\/j.clinre.2019.12.001_bib0335","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s12185-011-0980-y","article-title":"The role of body mass index and other body composition parameters in early post-transplant complications in patients undergoing allogeneic stem cell transplantation with busulfan-cyclophosphamide conditioning","volume":"95","author":"Sucak","year":"2012","journal-title":"Int J Hematol"},{"issue":"8","key":"10.1016\/j.clinre.2019.12.001_bib0340","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/lt.21600","article-title":"Monitoring mycophenolic acid pharmacokinetic parameters in liver transplant recipients: prediction of occurrence of leukopenia","volume":"14","author":"Hao","year":"2008","journal-title":"Liver Transplant"},{"issue":"8","key":"10.1016\/j.clinre.2019.12.001_bib0345","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/lt.20500","article-title":"Diarrhea in liver transplant recipients: etiology and management","volume":"11","author":"Ginsburg","year":"2005","journal-title":"Liver Transplant"},{"issue":"12","key":"10.1016\/j.clinre.2019.12.001_bib0350","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/lt.23530","article-title":"Risk of cytomegalovirus disease in high-risk liver transplant recipients on valganciclovir prophylaxis: a systematic review and meta-analysis","volume":"18","author":"Kalil","year":"2012","journal-title":"Liver Transplant"},{"issue":"1","key":"10.1016\/j.clinre.2019.12.001_bib0355","first-page":"61","article-title":"Risk factors for infection after liver transplantation. Best practice & research","volume":"26","author":"van Hoek","year":"2012","journal-title":"Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.clinre.2019.12.001_bib0360","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1399-3062.2009.00448.x","article-title":"Lower incidence of cytomegalovirus infection with everolimus versus mycophenolate mofetil in de novo cardiac transplant recipients: a randomized, multicenter study","volume":"12","author":"Vigano","year":"2010","journal-title":"Transpl Infect Dis"},{"issue":"10","key":"10.1016\/j.clinre.2019.12.001_bib0365","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/lt.23713","article-title":"Occult cytomegalovirus cholangitis as a potential cause of cholestatic complications after orthotopic liver transplantation?. A study of cytomegalovirus DNA in bile","volume":"19","author":"Gotthardt","year":"2013","journal-title":"Liver Transplant"},{"issue":"2","key":"10.1016\/j.clinre.2019.12.001_bib0370","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1067\/mge.2002.120813","article-title":"Biliary tract complications after orthotopic liver transplantation with choledochocholedochostomy anastomosis: endoscopic findings and results of therapy","volume":"55","author":"Rerknimitr","year":"2002","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"10.1016\/j.clinre.2019.12.001_bib0375","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/lt.25358","article-title":"Endoscopic management of benign biliary strictures after liver transplantation","volume":"25","author":"Larghi","year":"2019","journal-title":"Liver Transplant"},{"issue":"6","key":"10.1016\/j.clinre.2019.12.001_bib0380","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/liv.13995","article-title":"Endoscopic retrograde cholangiography and percutaneous transhepatic cholangiodrainage in biliary strictures after liver transplantation: Long-term outcome predictors and influence on patient survival","volume":"39","author":"Heinemann","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2019.12.001_bib0385","doi-asserted-by":"crossref","first-page":"218","DOI":"10.12659\/AOT.892393","article-title":"Immunological risk factors in biliary strictures after liver transplantation","volume":"20","author":"Mocchegiani","year":"2015","journal-title":"Annals Transplant"},{"issue":"8","key":"10.1016\/j.clinre.2019.12.001_bib0390","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1478-3231.2012.02810.x","article-title":"Genetic, immunological and clinical risk factors for biliary strictures following liver transplantation","volume":"32","author":"Iacob","year":"2012","journal-title":"Liver Int"},{"issue":"7","key":"10.1016\/j.clinre.2019.12.001_bib0395","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1034\/j.1600-6143.2003.00165.x","article-title":"Risk factors for and clinical course of non-anastomotic biliary strictures after liver transplantation","volume":"3","author":"Guichelaar","year":"2003","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.clinre.2019.12.001_bib0400","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1399-0012.2012.01632.x","article-title":"Use of immune function test in monitoring immunosuppression in liver transplant recipients","volume":"26","author":"Te","year":"2012","journal-title":"Clin Transplant"},{"issue":"Suppl. 3","key":"10.1016\/j.clinre.2019.12.001_bib0405","article-title":"Next level of immunosuppression: drug\/immune monitoring","volume":"17","author":"Levitsky","year":"2011","journal-title":"Liver Transplant"},{"key":"10.1016\/j.clinre.2019.12.001_bib0410","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.trim.2018.11.001","article-title":"Clinical use of an immune monitoring panel in liver transplant recipients: a prospective, observational study","volume":"52","author":"Iovino","year":"2019","journal-title":"Transplant Immunol"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740119302608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740119302608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:31:14Z","timestamp":1761895874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740119302608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S2210740119302608"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2019.12.001","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of mycophenolic acid on inosine monophosphate dehydrogenase (IMPDH) activity in liver transplant patients","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2019.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}